NESCO is like a tortoise that gets a dose of steroids every time an IT building is completed and then overtakes the hare in front. But the second generation is making the tortoise move steadily thanks to the exhibition, events and the food businesses. The next IT building/convention centre/hotel to be completed after 5-6 years will be like a shot of viagra. I feel in 10-12 years’ time, the entire complex would be completely built up and NESCO will be a dividend yield story.

disclosure: have been accumulating for more than a decade and biased.

Happy Diwali to the readers. This Diwali , I’ve ignored all the stock tips and bought some stocks from my own analysis during the Muhurat Trading.
I also plan to create a list of stocks that I think are a good investment in the next 1-2 years term and would like to track their performance over next 2 years. Everyone considers 1 years, but we don’t know how the market will perform over next years and what kind of headwinds or tailwinds could be there. So, I considered the timeframe to be 2 years. But will track intermittently over next 2 years.

Scrip	CMP in Rs	Reason
Fino Payments Bank	286.3	Expect 20% Revenue and 40% Profit CAGR over FY23 -26.
Shree Pushkar Chemicals	192.5	Business doing reasonably well in headwinds. Capex and industry turn around will drive growth for next 2 years
Mayur Uniquoters	517.5	Starting supplies to Auto OEMs (High Margin business). 15-20% CAGR FY23-26 and higher Profit growth
Mold-Tek Technologies	272	~20% CAGR growth company with good management. Acquisition in Design space would drive the Value addition and so the Revenue and Profit growth
Krsnaa Diagnostics	656	Best growth in Diagnostic industry for next 2 years. Cheapest and is poised to grow with earnings over Fy23-26
Benchmark: Nifty Smallcap 250 Index	12705.5	Benchmark to assess the performance

Note:

1. Prices are as of end of Muhurat Trading session (All stock went up ~2% already in the day).
2. Since most of the stocks are small caps, I’ve considered Nifty smallcap 250 index as the benchmark
3. This is pure fundamental based view and didn’t consider technicals for the selection
4. Out of these stocks I’ve bought Shree Pushkar chemicals and Mayur Uniquoters in my PF today

Disc: No recommendation by any means. Just a way to assess my stock selection process

Seems within the limits when it comes to Pharma/Healthcare companies, which are around 110 ~ 120 days. I think however good results are, some of us tend to find holes and in many times when holes are not there also

The stock just touched 10,000cr market cap today. I still remember “the big debate” a few years ago when many were simply adamant that this company will vanish because they couldn’t understand the fundamentals or the business. Anyway, next few years seems even more crucial for them given the amount of Capex they’re putting together. Good thing is, they’re doing it with internal accruals rather than take on debt. Would be interesting to see the ramp up once everything is completed.

Amazing run continues of share price, Impressive H1 results…H2 is supposed to be better as they had said PAT of 38 crore in FY 24 so H2 should be 23 crore and with that H2 FY 24 forward PE will be around 25 at current price. Execution remains on track, exploring external markets. Regulation is becoming favourable too. A long run ahead remains…